Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida
February 27, 2026
Increased adoption of clinical whole-genome sequencing is advancing diagnostics for rare diseases, which affect 15 million American children SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) today announced that Illumina Laboratory Services, Illumina's CLIA-certified laboratory, is providing clinical sequencing and interpretation services to the new Diagnostic Lab at Florida Institute for Pediatric Rare Diseases (IPRD) at Florida [...]
February 26, 2026
Integration of Takara Bio USA’s Trekker® reagent kit with Illumina’s Single Cell 3′ RNA Prep assay delivers high-density, high-sensitivity spatial data with true single-cell resolution SAN JOSE, Calif. -- Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., today announced that it presented a scientific poster at the Advances in Genome Biology [...]
February 26, 2026
Divestiture streamlines operations and advances the Company’s strategy to fully exit non-core activities LOS ANGELES -- Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announces the sale of its ChromaDex Reference Standards business to LGC, as of February 24, 2026, in [...]
February 26, 2026
The acquisition further enhances LGC’s ability to support pharmaceutical, food, and testing laboratories with trusted reference materials that underpin safety, quality, and regulatory confidence. London, UK -- LGC Group, a global leader in life sciences, diagnostics, and analytical solutions, today announced the acquisition of the ChromaDex Reference Standards portfolio from Niagen Bioscience (NASDAQ: NAGE). The acquisition expands [...]
Exum Instruments Launches Next Generation Massbox, Redefining Solid Sample Chemistry
February 26, 2026
New platform delivers faster operations, enhanced performance, and greater versatility for materials scientists, geoscientists, metallurgists, and battery developers DENVER, CO – Exum Instruments Inc. today announced the launch of next generation Massbox®, a significant advancement of its proprietary Laser Ablation Laser Ionization Time of Flight Mass Spectrometry (LALI-TOF-MS) platform. Developed to meet the growing demands [...]
Addgene Appoints Greg Crescenzi as Vice President of Global Commercial Strategy and Partnerships
February 26, 2026
WATERTOWN, Mass. -- Addgene, an organization committed to accelerating discovery and innovation by providing a vast catalog of expertly curated and quality-controlled research tools developed by researchers, today announced the appointment of Greg Crescenzi as Vice President of Global Commercial Strategy and Partnerships. With his leadership in commercializing industry-first products and technologies, Crescenzi will drive [...]
February 25, 2026
SPT Labtech to develop an automated sample preparation platform for Illumina to further optimize the efficiency and benefits of genomic workflows in decentralized healthcare settings Builds on success of existing partnership including development of automated library preparation methods on SPT Labtech’s firefly? platform The novel platform will enable decentralized labs to access the same level of [...]
February 25, 2026
SOLNA, Sweden -- Epigenica today announces the launch of EpiFinder™ cNUC, a truly unique product for liquid biopsies that significantly expands the capabilities of epigenomic research by delivering deep insights directly from circulating nucleosomes. As the first product capable of simultaneously profiling up to 5 histone post‑translational modifications together with DNA methylation across multiple samples, [...]
February 25, 2026
The new platform delivers unmatched quantitation, robustness, and throughput to support clinical translation of spatial proteomics assays ORLANDO, Fla. -- Bruker Corporation (Nasdaq: BRKR) announced the launch of CellScape™ XR, a next-generation spatial proteomics platform designed to advance the development of diagnostic and prognostic assays by delivering unprecedented quantitative performance, robustness, and flexibility. CellScape XR addresses [...]
February 25, 2026
FREMONT, Calif. and RENO, Nev. -- Ultima Genomics, a developer of ultra-high-throughput sequencing systems, together with Hamilton (Hamilton Company and Hamilton Bonaduz AG), a global leader in precision laboratory automation, today announced a partnership to automate Ultima's latest sample preparation and amplification technology across Hamilton's Microlab® STAR™ liquid handling platform. The collaboration enables scalable, efficient next-generation sequencing (NGS) workflows [...]

